CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
ViaLase
ViaLase logo

ViaLase

ViaLase: Pioneering image-guided laser surgical systems for precise and effective glaucoma treatment.

Corona del Mar, CA, US🇺🇸
Founded
2019
Overview
Compare
Fundraising
Employees
Library

Founded with a mission to revolutionize glaucoma treatment, ViaLase develops advanced image-guided femtosecond laser surgical systems. The company's core product, the ViaLuxe™ Laser System, aims to reduce intraocular pressure (IOP) by creating customized drainage channels through the trabecular meshwork using micron-accurate optical coherence tomography (OCT) imaging. ViaLase focuses on providing non-invasive, precision-based solutions for glaucoma patients, addressing a significant need in the ophthalmology market.

ViaLase has garnered attention from notable investors and industry experts for its innovative approach to glaucoma treatment. The company's technology is currently pending regulatory clearance, reflecting its commitment to meeting stringent medical standards. By leveraging cutting-edge laser and imaging technologies, ViaLase aims to make a substantial impact on the quality of life for glaucoma patients worldwide, setting new standards in ophthalmic surgery.

ViaLase - Similar Companies

Iridex logo

Iridex

iridex.com

Biolase logo

Biolase

biolase.com

Capsulaser logo

Capsulaser

capsulaser.com

Ace Vision Group logo

ViaLase - Quick Facts

Who are ViaLase's competitors?

Companies similar to ViaLase include Iridex, Biolase, Capsulaser and Ace Vision Group.

When was ViaLase founded?

ViaLase was founded in 2019.

Where is ViaLase's headquarters located?

ViaLase's headquarters is located in Corona del Mar, CA, US.

When was ViaLase's last funding round?

ViaLase's most recent funding round was for $2.3M (USD) in January 2024.

How much disclosed funding has ViaLase raised?

As of Jan 18, 2024, ViaLase has disclosed funding of $37.7M (USD). Undisclosed round amounts are excluded.

ViaLase - Classification

Industry
  • Hardware
Ownership
  • Venture-backed
Technology
  • Laser Technology

How many employees does ViaLase have?

ViaLase has 25 employees as of Feb 5, 2024.

Geographic Exposure
  • Americas
Revenue
  • Transactional
Customer
  • Enterprise
Main Product
  • Surgical Systems
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified

Ace Vision Group

acevisiongroup.com

Cutera logo

Cutera

cutera.com

Proto Lase logo

Proto Lase

protolase.com

Surgilight logo

Surgilight

Glaukos logo

Glaukos

glaukos.com

Myra Vision logo

Myra Vision

myravision.com

STAAR Surgical logo

STAAR Surgical

staar.com

Full Spectrum Laser logo

Full Spectrum Laser

fslaser.com

BellaMia Technologies logo

BellaMia Technologies

Trimedyne logo

Trimedyne

trimedyne.com

Novian Health logo

Novian Health

novianhealth.com

Omniguide logo

Omniguide

omni-guide.com